Santhera Pharmaceuticals Holding AG (LON:0QN1)

Revenue by Product

Financials in millions CHF. Fiscal year is January - December.

Year Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Specialty Niche Products	103.41M
Specialty Niche Products Growth	1283.84%

Revenue by Geography

Financials in millions CHF. Fiscal year is January - December.

Year Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
North America	98.09M
Europe	3.40M
Europe Growth	-191.53%
Asia	1.92M
Asia Growth	-82.83%